Thomas Duthy

Thomas Duthy is the founder of Nemean Group Pty Ltd., founded in 2018, holding the title of Chief Executive Officer & Director.
Current jobs include Non-Executive Chairman at OncoSil Medical Ltd. starting in 2025; Non-Executive Director at Liver Foundation of Western Australia; Investor Relations Contact at Limeade, Inc.; Member at Australian Institute of Co. Directors; Member at Australasian Investor Relations Association Ltd; and Investor Relation Contact at Mayne Pharma Group Ltd. Former jobs include Non-Executive Chairman at Arovella Therapeutics Ltd. from 2023 to 2025; Independent Non-Executive Director at Vitasora Health Ltd. in 2018; Non-Executive Director at Vitasora Health Ltd. from 2020 to 2022; Executive Director at Neurotech International Ltd. from 2022 to 2025; Non-Executive Director at Neurizon Therapeutics Ltd. in 2024; Executive Director at Invex Therapeutics Ltd. from 2020 to 2025; Head-Investor Relations at Nova Eye Medical Ltd.; Global Head-Investor Relations at Sirtex Medical Pty Ltd.; and Analyst at Taylor Collison Ltd. Education includes a doctorate from the University of Adelaide and an MBA from Deakin University.